Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Beginning Cash Balance (2019 - 2025)

Burning Rock Biotech has reported Beginning Cash Balance over the past 7 years, most recently at $66.8 million for Q4 2025.

  • For Q4 2025, Beginning Cash Balance fell 2.17% year-over-year to $66.8 million; the TTM value through Dec 2025 reached $275.5 million, down 13.88%, while the annual FY2025 figure was $74668.0, 11.41% down from the prior year.
  • Beginning Cash Balance for Q4 2025 was $66.8 million at Burning Rock Biotech, up from $63.9 million in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $327.2 million in Q2 2021 and troughed at $63.9 million in Q3 2025.
  • A 5-year average of $149.6 million and a median of $105.6 million in 2023 define the central range for Beginning Cash Balance.
  • Biggest five-year swings in Beginning Cash Balance: surged 1987.38% in 2021 and later tumbled 57.02% in 2023.
  • Year by year, Beginning Cash Balance stood at $258.9 million in 2021, then decreased by 19.4% to $208.7 million in 2022, then tumbled by 57.02% to $89.7 million in 2023, then decreased by 23.89% to $68.3 million in 2024, then decreased by 2.17% to $66.8 million in 2025.
  • Business Quant data shows Beginning Cash Balance for BNR at $66.8 million in Q4 2025, $63.9 million in Q3 2025, and $72.9 million in Q2 2025.